Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer.

[1]  J. Stockman,et al.  Association Between Smoking and Risk of Bladder Cancer Among Men and Women , 2013 .

[2]  J. Gore,et al.  Impact of a bladder cancer diagnosis on smoking behavior. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Y. Lotan,et al.  Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. , 2012, European urology.

[4]  M. Pike,et al.  Cigarette smoking and subtypes of bladder cancer , 2012, International journal of cancer.

[5]  T. Guzzo,et al.  Smoking knowledge assessment and cessation trends in patients with bladder cancer presenting to a tertiary referral center. , 2012, Urology.

[6]  M. Babjuk,et al.  [EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update]. , 2012, Actas urologicas espanolas.

[7]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[8]  J. Witjes,et al.  Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer. , 2011, European urology.

[9]  S. Shariat,et al.  Impact of smoking on outcomes after intravesical bacillus Calmette–Guérin therapy for urothelial carcinoma not invading muscle of the bladder , 2011, BJU international.

[10]  G. Dalbagni,et al.  Bacillus Calmette-Guérin without maintenance therapy for high-risk non-muscle-invasive bladder cancer. , 2011, European urology.

[11]  Vital signs: current cigarette smoking among adults aged ≥18 years--United States, 2005-2010. , 2011, MMWR. Morbidity and mortality weekly report.

[12]  S. Dube,et al.  Vital signs: Current cigarette smoking among adults aged >=18 years --- United States, 2009 , 2010 .

[13]  R. T. Divrik,et al.  Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. , 2010, European urology.

[14]  G. Dalbagni.  Editorial comment on: detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. , 2010, European urology.

[15]  K. Grigor,et al.  Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. , 2010, European urology.

[16]  J. Ro,et al.  Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer. , 2009, The Journal of urology.

[17]  A. Jemal,et al.  Tobacco Control in the United States—Recent Progress And Opportunities , 2009, CA: a cancer journal for clinicians.

[18]  J. Montie,et al.  The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation. , 2008, The Journal of urology.

[19]  K. Grigor,et al.  DETRUSOR MUSCLE IN THE FIRST TRANSURETHRAL RESECTION OF BLADDER TUMOUR (TURBT) SPECIMEN IS A SURROGATE MARKER OF RESECTION QUALITY AND IS DEPENDANT ON OPERATOR EXPERIENCE , 2008 .

[20]  P. Schellhammer,et al.  Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. , 2007, The Journal of urology.

[21]  C. Shun,et al.  Stopping smoking might reduce tumour recurrence in nonmuscle‐invasive bladder cancer , 2007, BJU international.

[22]  Y. Lotan,et al.  Precystectomy nomogram for prediction of advanced bladder cancer stage. , 2006, European urology.

[23]  D. Vidrine,et al.  Successes and failures of the teachable moment , 2006, Cancer.

[24]  M. Zeegers,et al.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review , 2003, World Journal of Urology.

[25]  P. Adab,et al.  Does smoking status influence the prognosis of bladder cancer? A systematic review , 2002, BJU international.

[26]  N. Betts,et al.  Clustering of Lifestyle Behaviors: The Relationship between Cigarette Smoking, Alcohol Consumption, and Dietary Intake , 2000, American journal of health promotion : AJHP.

[27]  T. Wheeler,et al.  Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder. , 2000, Urology.

[28]  E Dorant,et al.  The impact of characteristics of cigarette smoking on urinary tract cancer risk , 2000, Cancer.

[29]  P. Russo,et al.  Influence of smoking status on the disease‐related outcomes of patients with tobacco‐associated superficial transitional cell carcinoma of the bladder , 1999, Cancer.

[30]  Suzanne G. Leveille,et al.  Smoking, Physical Activity, and Active Life Expectancy , 1999 .

[31]  B. Têtu,et al.  Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  W. M. Linehan,et al.  Associations between Bladder Cancer Risk Factors and Tumor Stage and Grade at Diagnosis , 1994, Epidemiology.